Major players in the testosterone replacement therapy market are AbbVie Inc., Acerus Pharmaceuticals Corporation, Antares Pharma Inc., Bayer AG, BioTE.
/PRNewswire/ The testosterone replacement therapy market size is forecast to increase by USD 439.67 million from 2022 to 2027, at a CAGR of 3.38%, according.
/PRNewswire/ The testosterone replacement therapy market report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 3.1%.